Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 26)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CUR11$25  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
17-Apr-14New Constructs, LLCN/ACUR: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
16-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - NEURALSTEM, INCORPORATION. (CUR-A)11$25  View Abstract
16-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - DIAGNOCURE INC. (CUR-T)11$25  View Abstract
12-Apr-14Reuters Investment ProfileN/AQuilicura SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
12-Apr-14Reuters Investment ProfileN/ADiagnocure Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
12-Apr-14Pechala's ReportsFrantisek PechalaNEURALSTEM INC (CUR) 12-months forecast1$15  View Abstract
12-Apr-14Reuters Investment ProfileN/ANeuralstem Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
11-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Diagnocure Inc.42$75  View Abstract
Next 16

Independent Reports (Showing 1 to 10 of 26)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
17-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CUR11$25View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
17-Apr-14New Constructs, LLCN/ACUR: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
16-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - NEURALSTEM, INCORPORATION. (CUR-A)11$25View Abstract
16-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - DIAGNOCURE INC. (CUR-T)11$25View Abstract
12-Apr-14Reuters Investment ProfileN/AQuilicura SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
12-Apr-14Reuters Investment ProfileN/ADiagnocure Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
12-Apr-14Pechala's ReportsFrantisek PechalaNEURALSTEM INC (CUR) 12-months forecast1$15View Abstract
12-Apr-14Reuters Investment ProfileN/ANeuralstem Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
11-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Diagnocure Inc.42$75View Abstract
Next 16

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.